Institute for Heart, Vascular and Stroke Care

Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present their experience and provide a practical guide to clinical decision making for patients with heart failure, pulmonary embolism and cardiogenic stroke.

Advanced Cardiovascular Technologies: Who, When, Why?
Patient Selection Strategies to Optimize Therapeutic Outcomes


Sunday, November 17, 2013

7:00 pm - 9:30 pm
Hyatt Regency Dallas
300 Reunion Boulevard
Dallas, TX 75207

Complimentary transportation will be provided to and from the Dallas Convention Center.

Advanced Technologies: When, Who, Why? Patient Selection to Optimize Therapeutic Outcomes will examine the role of novel intervention strategies and innovative devices available for the management of complex cardiovascular disorders and prevention of cardioembolic stroke. This course will outline evidence-based approaches to patient selection for these interventions, which will impact practice and optimize therapeutic outcomes for patients with heart disease, pulmonary embolism and stroke. Faculty will share their experience and provide a practical guide to clinical decision making for patients with heart failure, pulmonary embolism and cardiogenic stroke in a format that will allow for an interactive exchange with the audience.


Register now

SPEAKERS

Course Objectives

Upon completion of this course, participants will be able to:

  • Appropriately select candidates for mechanical assist device implantation
  • Utilize approaches to manage pulmonary embolism, including pharmacologic and mechanical interventions
  • Identify available technology and the indications for ECMO
  • Evaluate the impact of current clinical trial data on treatment options for cardioembolic stroke including left atrial appendage closure devices
  • Discuss the mechanisms of cardioembolic stroke and secondary stroke prevention strategies, including anti-platelet therapy, anticoagulation and PFO closure
  • Provide appropriate care and counsel for patients and their families
  • Program Agenda

    7:00 pm     Registration and Dinner

    7:10 pm     Introduction
                         • Natalia S. Rost, MD, MPH
                         • Thoralf M. Sundt, MD

    7:20 pm     The Changing Face of Mechanical Circulatory
                        Support
    for Congestive Heart Failure and Pulmonary  
                        Embolism: Do Device Improvement Support Early
                        Intervention?

                        Ventricular Assist Devices or Home Inotropic
                        Support While Awaiting Cardiac Transplantation
                          • Jose P. Garcia, MD

                        When Should My Heart Failure Patient Get a
                        Destination VAD?
                          • Gregory D. Lewis, MD

                       Anticoagulation and Interventions for Pulmonary Embolism: Who Will Benefit?
                           • Michael R. Jaff, DO

                       Shifting the Paradigm for Pulmonary Embolism With ECMO
                           • Thoralf M. Sundt, MD

    8:20 pm    Questions and Answers                                       

    8:30 pm     Interventions for Cardioembolic Stroke: Are They Effective?

                       Sources of Cardioembolic Stroke
                         • Natalia S. Rost, MD, MPH

                       The Role of PFO Closure in Stroke Prevention: A Multidisciplinary Team Approach
                         • Ignacio Inglessis, MD

                       Managing the Fibrillating Left Atrial Appendage: When a Medical Approach is Not Enough
                         • Moussa C. Mansour, MD

    9:15 pm       Questions and Answers

    9:25 pm       Closing Remarks

    Target Audience

    Cardiothoracic surgeons, clinical cardiologists, internists, interventional cardiologists, stroke neurologists, vascular surgeons and cardiovascular nurses

    Accreditation Statement

    This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Massachusetts General Hospital. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation

    Physicians: Postgraduate Institute for Medicine designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Accreditation Statement

    Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    Credit Designation

    This educational activity for 2.3 contact hours is provided by Postgraduate Institute for Medicine.

    Disclosure of Conflicts of Interest

    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

    Americans with Disabilities Act

    Event staff can assist you with any special needs (i.e., physical, dietary, etc). Please contact Gina Amatruda prior to the live event at 203-915-3975.

     

    Jointly sponsored/co-provided by:

    Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care

    Postgraduate Institute for Medicine

    This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.